NFKBIA and Alzheimer disease: Moreover, DNCB exposure resulted in increased phosphorylation levels of TAK1 and IκBα, critical regulators of NF-κB activation; however, treatment with I3C led to a notable reduction in phosphorylation levels in DNCB-induced AD mice (Fig. 5C).